Relative inhibitory activities of the eluted fractions on the contractile responses to SP (10 nM) and acetylcholine (ACh, 100 nM) of the guinea pig ileum are shown by black bars.
Since the report of the first nonpeptide tachykinin receptor antagonist, CP-96,345, 1) a large number of nonpeptide tachykinin antagonists have been reported. Among these, tachykinin NK 1 receptor antagonists are most numerous and probably most important because the NK 1 receptor is predominant in the human central nervous system, 2) and because the selective endogenous ligand for NK 1 receptor, substance P (SP), is most abundant among tachykinin peptides in both central and peripheral nervous systems of various species. It was shown that many tachykinin NK 1 receptor antagonists block the neurotransmitter action of SP mediated by NK 1 receptors.
3) Clinical application of NK 1 antagonists for various diseases has been a target of many recent studies, and indeed a successful treatment of depression and anxiety by an NK 1 antagonist, MK 806, was reported. 4) Most of the NK 1 antagonists so far reported are synthetic, and a few of them are of microbial origin but of low potencies. 5, 6) No potent tachykinin NK 1 antagonist from natural sources has been reported. In this paper we report a new potent tachykinin NK 1 receptor antagonist obtained from the extracts of plants of Compositae. A preliminary report has been published as a patent application No. P2000-256293A.
7)

Results
Extraction, Isolation and Structure Determination Dried flower heads of Matricaria chamomilla L. were extracted with MeOH at room temperature. A small portion of the MeOH extract was subjected to octadecyl silica (ODS) column chromatography. The obtained fractions were dried and submitted to the bioassay for tachykinin NK 1 receptor antagonist activity using the isolated guinea pig ileum. Figure 1 shows the chromatogram monitored by UV (300 nm) and the activities of the fractions. The major peak of active fractions, exhibiting the NK 1 antagonist activity, was eluted with the retention time from 10.8 to 12.4 min. These fractions, however, did not show any anticholinergic activity.
The residual major part of the MeOH extract, therefore, was partitioned between n-hexane and H 2 O. The H 2 O layer was further partitioned between n-BuOH and H 2 O. The nBuOH layer was subjected to a silica gel column chromatography. The active compound (1a) was obtained in pure form as a white powder by repeated reversed phase HPLC.
The molecular formula of 1a was determined to be C 46 On the other hand, catalytic hydrogenation of 1a gave a single product (6) which showed pseudo-molecular ion at m/z 795 ( [MϩH] ϩ ) in the secondary ion (SI)-MS spectrum. Since, as compared with 6, 1a possessed 8 more protons at d 6.36-7.56 and 16 less protons at d 2.24-3.02 in the 1 H-NMR spectrum, the presence of four olefins in 1a was suggested. After acid hydrolysis of 6, the hydrolysate was partitioned between H 2 O and n-BuOH. The n-BuOH extract contained 3-(4-hydroxyphenyl)propanoic acid as a single compound, whose 1 H-NMR spectrum and retention time in HPLC analysis were identical with those of the authentic compound, whereas the H 2 O extract contained spermine as a sole compound, which was identical with the authentic compound in 1 H-NMR spectra 5) and in HPLC analysis.
7)
The structure of 6 was, therefore, presumed to be N1,N5,N10,N14-tetrakis [3-(4-hydroxyphenyl) propanoyl]-1,5,10,14-tetraazatetradecane and confirmed by direct comparison of its Rf value in TLC (silica gel, MeOH-EtOAc, 1 : 9), retention time in HPLC, and 1 H-NMR chemical shifts with those of the synthetic material (see Experimental section).
Since 1a possessed four olefins, the structure of 1a was easily deduced to be N1,N5,N10,N14-tetrakis [3-(4- hydroxyphenyl)-2-propenoyl]-1,5,10,14-tetraazatetradecane (Fig. 2) , which was confirmed by direct comparison with the synthetic sample in a manner similar to that for 6 (see Experimental section).
A ninhydrin positive analog of 1a, designated as 2, was also isolated from CHCl 3 -MeOH-H 2 O (10 : 5 : 1) eluates in silica gel column chromatography of the MeOH extract. The structure of 2 was deduced to be N1,N5,N10-tris [3-(4- hydroxyphenyl)-2-propenoyl]-1,5,10,14-tetraazatetradecane (Fig. 2) by instrumental analyses of trifluoroacetic acid (TFA) salt of 2, its reduction product, and its acid-hydrolysates (see Experimental section).
Distribution of Coumaroyl Spermines
The extracts of about 200 species of plants were screened for NK 1 antagonist activity by the use of guinea pig ileum, and when the active extracts were found, the presence of 1a was examined in the extracts by HPLC (see Experimental section). As a result, 1a was found in flowers of 6 species of Compositae. In four species examined, 1a was found in tubular but not in ligulate flowers. In both German and Roman chamomiles (Matricaria chamomilla L. and Anthemis nobilis L.), 1a was specifically concentrated in pollen (Table 1 ). In addition, we found 2 in pollen and tubular flowers of both German and Roman chamomiles.
Structure-Activity Relationship A number of compounds with structures related to that of 1a were synthesized by the methods shown in Charts 1-3. Thus, the acid chlorides 3a-g [8] [9] [10] [11] [12] ) and 5 13) prepared from the corresponding carboxylic acids were condensed with spermine or its analogs to give the amides 4a-g, whose protecting groups were saponified with 1 N NaOH to afford 1a-d, g, 6, 10-12. The activities of these amides as tachykinin NK 1 receptor antagonists were estimated by their inhibitory actions on SP-induced contraction of the guinea pig ileum and by their competitive inhibition of the binding of [ Table 2 . Most of the other derivatives were inactive. Modification of the coumaroyl group (1b-d, g, 4a, e, f, 6) as well as the spermine skeleton (10-12) resulted in reduction of activity. The results suggest that the structure of 1a is considerably optimized for the antagonist activity on the guinea pig and human NK 1 receptors. In contrast with the inactivity of 2, the activity of 10 was noteworthy indicating that the lack of one coumaroylaminopropyl moiety of 1a does not abolish the NK 1 antagonist activity completely. This difference may be due to the difference between their stable conformations. A hypothesis was postulated that two phenyl rings with specific relative spatial orientation may be an important factor for the NK 1 antagonist activity.
14) 1a and 10, however, were too flexible to pre- 
Inula britanica L. Effects of 1a on the Receptors Other Than NK 1 In order to examine the specificity of the action of 1a as an NK 1 receptor antagonist, its effects on other types of receptors were studied. 1a at a concentration of 300 nM did not displace the concentration-contractile response curves on the guinea pig ileum to ACh, histamine and bradykinin. Moreover, 1a altered neither the concentration-contractile response curves to neurokinin A (NK 2 receptor agonist) on the rat vas deferens, an NK 2 monoreceptor system, 15) nor the contraction of the rat portal vein, an NK 3 monoreceptor system, 15) evoked by senktide (NK 3 receptor agonist, 10 nM).
Discussion
The original purpose of the present study was to find in the plant kingdom clinically efficacious antagonists for tachykinin NK 1 receptors. In this respect, although 1a is a potent NK 1 receptor antagonist, this compound appears unlikely to serve as a clinically useful drug for the following reasons. Firstly, the solubility of 1a in water and human plasma is extremely low. The estimated maximal concentration of 1a in the human plasma after deproteination was around 10 nM, and when 1a was dissolved in non-deproteinated human plasma, it did not display any inhibitory action on the binding of
11 ]SP to human NK 1 receptors expressed on CHO cells. Secondly, when 1a, dissolved in 0.5% carboxymethyl cellulose sodium salt solution, was orally administered in rats, 1a was not detected in the blood. It is noteworthy that several commercially available preparations of chamomile were found to contain significant amounts of 1a, which, if it were absorbed efficiently from gastrointestinal tract, could afford a significant concentration in the blood. However, when these preparations were orally administered in rats, again 1a was not detected in the blood (unpublished observation). Therefore, it seems unlikely that the effects of the chamomile preparations administered orally in humans, such as anti-inflammatory and anti-asthmatic effects, involve the inhibition of tachykinin NK 1 receptors induced by 1a.
In conclusion, we have discovered a new nonpeptide tachykinin NK 1 antagonist, 1a, in the extracts of the plants of Compositae. Compound 1a is the first alkaloid with a potent NK 1 receptor antagonist activity from natural sources and has a unique structure, which is entirely different from those of the previously reported synthetic NK 1 antagonists.
Experimental
General Melting points were determined on a Yamato MP-21 melting point apparatus and are uncorrected. UV spectra were recorded on a Beckman DU 650 spectrophotometer and IR spectra on a Horiba FT-200 Fourier transform (FT) IR spectrophotometer.
1 H-NMR spectra were taken on a Bruker ARX-500 (500 MHz A portion of the residue (20 mg) was subjected to preparative HPLC [column, STR PREP-ODS, 20ϫ250 mm; eluent, 0.1% TFA-MeOH (30 : 70) (0-6 min), 0.1% TFA-MeOH (30 : 70)→MeOH (6-16 min, linear gradient), MeOH (16-30 min); flow rate, 8 ml/min; column temperature, ambient; detection, 300 nm] and fractionated. 2% aliquot of each fraction was dried and dissolved in 10 ml dimethylsulfoxide (DMSO), and added to 5 ml Tyrode solution followed by application to the ileum (Fig. 1) .
A residual part of the MeOH extract (78 g) was suspended in water (1 l) and extracted with n-hexane (0.5 l). The obtained aqueous layer was further extracted with n-BuOH (0.5 l). The n-BuOH extract (20.5 g) was subjected to silica gel column chromatography (5ϫ40 cm), and elution was carried out in steps with a mobile phase of CHCl 3 -MeOH (10 : 1, yield 5. 
Acid Hydrolysis of 6
The compound 6 (25 mg) in 6 N HCl (1 ml) was heated at 110°C for 24 h. The reaction mixture was concentrated and partitioned between H 2 O (5 ml) and n-BuOH (5 ml). The H 2 O layer and the nBuOH layer were concentrated to yield an H 2 O extract (21 mg) and n-BuOH extract (11 mg 
HPLC Analysis of Hydrolysate of 6
The analysis of spermine was performed with the on-column method of Saito et al. 16) with minor modification. Briefly, a 1 ml aliquot of the H 2 O layer was injected into a reverse phase column (YMC-Pack Polymer C18, YMC, 4.6ϫ250 mm). The mobile phase was a mixture of 50 mM sodium borate buffer (pH 9.9)-acetonitrile (77 : 23, v/v) containing 2 mM o-phthalaldehyde and 2 mM N-acetyl-L-cysteine. The flow rate was adjusted to 0.8 ml/min and the peaks were detected at excitation and emission wavelengths of 330 and 430 nm, respectively. The separation was performed at a temperature of 40°C. The water-soluble derivative thus obtained showed a single peak at 10.5 min, identical to that of authentic spermine.
The analysis of 3-(4-hydroxyphenyl)propanoic acid was carried out on YMC-Pack Polymer C18 (CH 3 CN-10 mM phosphate buffer pH 2.0, 22 : 78) at a temperature of 30°C. The mobile phase was delivered isocratically at a flow rate of 1.0 ml/min. The detection wavelength was set to 280 nm and a 4 ml aliquot of the n-BuOH layer was injected. A single peak at a retention time of 13.8 min was identical to that of authentic 3-(4-hydroxyphenyl)-propanoic acid.
Catalytic Hydrogenation of 2 and Acid Hydrolysis of Its Reduction Product A solution of 2 (17 mg) in MeOH (15 ml) was stirred with 10% Pd/C (5 mg) at room temperature for 4 h under an H 2 atmosphere. The reaction mixture was filtered, and the filtrate was concentrated. The residue gave a pseudo-molecular ion at m/z 647 (MϩH) ϩ in the SI-MS spectrum. A portion of the material was hydrolyzed in 6 N HCl (1 ml) at 110°C for 24 h. The hydrolysate was concentrated and partitioned between H 2 O (4 ml) and nBuOH (4 ml). The analysis of each layer was performed by HPLC with the same conditions as for 6. The H 2 O layer was found to contain spermine, and the n-BuOH layer contained 3-(4-hydroxyphenyl)propanoic acid.
HPLC Analysis of Coumaroyl Spermines (1a, 2) Plant materials were powdered and extracted by percolation with 10 volume of MeOH at room temperature in the dark. The MeOH solution was concentrated, and the residue was dissolved in DMSO. The quantification of 1a and 2 in the extracts was performed by HPLC using 1a and 2 isolated from Matricaria chamomilla L. as standards (Develosil ODS-HG-5, 4.6ϫ250 mm, Nomura Chemical, 50 mM phosphate buffer (pH 2.5)-MeOH (48 : 52), 1 ml/min, 40°C, UV at 300 nm, t R of 1a and 2: 10.4 and 4.1 min, respectively).
Synthesis. Preparation of the Acid Chlorides
The acid chlorides 3a, 8) 3b, 9) 3c, 10) 3d, 11) 3e, 12) and 5 13) were prepared from the corresponding carboxylic acids by the reported procedures. 3-Phenyl-2-propenoyl chloride (3f) was obtained from Aldrich.
(E)-3-(4-Acetoxyphenyl)-2-methyl-2-propenoyl Chloride (3g) A mixture of 4-hydroxybenzaldehyde (9.3 g, 76.2 mmol), methylmalonic acid (18.0 g, 150 mmol), and piperidine (15 ml) in pyridine (10 ml) was stirred at 100°C for 25 h. The reaction mixture was poured into 2 N HCl and extracted with EtOAc. The extract was washed with brine, dried, and condensed to give a solid, which was recrystallized from EtOAc to give (E)-3-(4-hydroxyphenyl)-2-methyl-2-propenoic acid ( 1H, s) . The acid obtained was acetylated with acetic anhydride (10 ml) in pyridine (50 ml) at room temperature for 5 h. The mixture was condensed and partitioned between EtOAc and water. The organic layer was washed with brine, dried, and subjected to silica gel column chromatography (CHCl 3 -MeOH, 9 : 1) to give (E)-3-(4-acetoxyphenyl)-2-methyl-2-propenoic acid (3.6 g, 70%) as crystals: mp 142-144°C. 1 1H, s) . A mixture of the propenoic acid (3.4 g, 15.6 mmol) and thionyl chloride (5 ml) in CH 2 Cl 2 was stirred at room temperature for 24 h. The reaction mixture was condensed to give quantitatively the acid chloride 3g as a pale yellow oil, which was applied to the next step without further purification.
Condensation of Acid Chlorides with Spermine. N1,N5,N10,N14-Tetrakis[3-(4-acetoxyphenyl)-2-propenoyl]-1,5,10,14-tetraazatetradecane (4a) The acid chloride 3a (4.7 g, 20.9 mmol) was added to a solution of spermine (1.0 g, 5.0 mmol) and Et 3 N (2.1 g, 21.0 mmol) in dry tetrahydrofuran (THF) (80 ml) at 0°C under an argon atmosphere. The mixture was stirred at an ambient temperature overnight and diluted with 10-fold volume of water. The precipitated solid was filtered, washed with water, and dried to give 4a as a white solid (4.0 g, 83% yield): mp 171-173°C. 1 N1,N5,N10,N14-Tetrakis[3-(4-hyroxyphenyl)-2-propenoyl]-1,5,10,14-tetraazatetradecane (1a) The compound 4a (954 mg, 1.0 mmol) was hydrolyzed with 1 N NaOH (4.8 ml) at room temperature for 1 h. The reaction mixture was neutralized with 1 N HCl (4.8 ml) and the solid precipitated was filtered, washed with water, and dried to give 1a (676 mg, 86%) as a white solid: mp 138-140°C (dec). 
